Category: Multiple Sclerosis (MS)
Multiple Sclerosis (MS) market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Multiple Sclerosis Drugs
The 2025-2030 World Outlook for Multiple Sclerosis Drugs This study covers the world outlook for multiple sclerosis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Multiple Sclerosis Treatments
The 2025-2030 World Outlook for Multiple Sclerosis Treatments This study covers the world outlook for multiple sclerosis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis
The 2025-2030 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis This study covers the world outlook for beta interferon therapeutics for multiple sclerosis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ear ... Read More
-
The 2025-2030 World Outlook for Multiple Sclerosis Therapeutics
The 2025-2030 World Outlook for Multiple Sclerosis Therapeutics This study covers the world outlook for multiple sclerosis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
Research Assistance
